Financial News
Latest News about BNTX
Recent news which mentions BNTX
NIH-Backed US Study Of Mixed COVID-19 Vaccines Regime To Conclude Soon: CNBC
September 29, 2021
From Benzinga
Is Moderna's Booster COVID-19 Shot Moving Closer to Authorization?
September 29, 2021
From Benzinga
CDC study finds side effects from COVID-19 vaccine booster are the same as after second shot, as experts urge unvaccinated to get their first shots
September 29, 2021
From MarketWatch
The Delta Variant Has Made Quest Diagnostics Indispensable
September 29, 2021
From Motley Fool
Pfizer’s COVID vaccine for kids might not get FDA approval until November
September 28, 2021
From MarketWatch
Is there an economic argument for COVID-19 boosters?
September 28, 2021
From MarketWatch
Why Pfizer, BioNTech, Moderna, and Novavax Stocks Are Falling Today
September 28, 2021
From Motley Fool
Hopes rise that Pfizer COVID-19 vaccine will be authorized for use in children aged 5 to 11 by late October, and Russia suffers worst one-day death toll
September 28, 2021
From MarketWatch
The Daily Biotech Pulse: Eisai, Biogen Pursue Approval Of Second Alzheimer's Treatment; Sanofi Changes mRNA Strategy; GSK Subsidiary To Develop Long-Acting HIV Preventive
September 28, 2021
From Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
September 28, 2021
From Benzinga
Sanofi Stops Work On Its mRNA COVID-19 Vaccine: What You Need To Know
September 28, 2021
From Benzinga
Pfizer Joins Influenza Vaccine Race, Kick Starts Early-Stage Trial
September 28, 2021
From Benzinga
3 COVID Stocks Ready to Take On the Delta Variant
September 27, 2021
From Motley Fool
Why Are the Nasdaq's Top Growth Stocks Freaking Out Monday?
September 27, 2021
From Motley Fool
Red COVID? Coronavirus deaths are highest in counties with the largest share of Trump voters: report
September 27, 2021
From MarketWatch
Why BioNTech, Moderna, and Novavax Stocks Are Sliding Today
September 27, 2021
From Motley Fool
Novavax and the Changing Covid-19 Vaccine Game
September 27, 2021
From InvestorPlace
Pfizer CEO says company to submit data on COVID-19 vaccine trial in children aged 5 to 11 within days, as U.S. daily death toll remains above 2,000
September 27, 2021
From MarketWatch
Pfizer Stock: Vaccine Crown Not Enough as Profit King Status Comes Next
September 27, 2021
From InvestorPlace
Thinking of Buying Pfizer Stock? Here's What You Need to Know
September 27, 2021
From Motley Fool
Wondering if your job makes you eligible for a booster shot? An answer may be not be forthcoming
September 27, 2021
From MarketWatch
Pfizer CEO Says People Needing COVID-19 Vaccines Every Year Is The 'Most Likely Scenario'
September 27, 2021
From Benzinga
Is Novavax Delaying Its COVID Vaccine EUA Filings Yet Again?
September 26, 2021
From Motley Fool
CDC head overrules advisers to allow COVID-19 boosters be offered to at-risk workers, and Biden urges eligible to act fast
September 24, 2021
From MarketWatch
Sinovac's COVID-19 Vaccine Shows Efficacy, But Lags Rivals In Malaysian Study: Reuters
September 24, 2021
From Benzinga
Pfizer/BioNTech COVID-19 Boosters For Seniors, Certain Vulnerable Adults Coming Soon - CDC Panel Recommends
September 24, 2021
From Benzinga
Why Are Top Scientists Opposing COVID Boosters?
September 24, 2021
From Motley Fool
Why BioNTech Thrashed the Market on Thursday
September 23, 2021
From Motley Fool
EMA To Decide On Pfizer/BioNTech COVID-19 Booster Next Month: Reuters
September 23, 2021
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
